Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Applying DMG-Na to the skin increases blood flow and may help with skin conditions.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Researchers found WNT10A to be a key gene in developing goat hair follicles.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Winter provides the best fur quality for Rex rabbits due to seasonal changes in specific signaling pathways.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

A balanced diet with proteins, vitamins, and minerals is crucial for managing skin disorders.